Allen & Overy (A&O) has advised pharma giant Novartis on its $28bn (£17.4bn) acquisition of a majority stake in Alcon, the world's largest eye-care company, reports The Am Law Daily. The deal is the second stage of a larger transaction originally struck in spring 2008, when Novartis purchased a 25% stake in Alcon for $10.4bn (£6.5bn), handing the company an option to purchase the 52% of the company owned by Nestle.
January 05, 2010 at 05:31 AM
1 minute read
The original version of this story was published on Legalweek
Allen & Overy (A&O) has advised pharma giant Novartis on its $28bn (£17.4bn) acquisition of a majority stake in Alcon, the world’s largest eye-care company, reports The Am Law Daily.
The deal is the second stage of a larger transaction originally struck in spring 2008, when Novartis purchased a 25% stake in Alcon for $10.4bn (£6.5bn), handing the company an option to purchase the 52% of the company owned by Nestle.
Presented by BigVoodoo
Celebrate outstanding achievement in law firms, chambers, in-house legal departments and alternative business structures.
The African Legal Awards recognise exceptional achievement within Africa s legal community during a period of rapid change.
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
